Dr. Edward Fung Chan, MD

Dr. Chan practices at Leonard Dzubow Ambulatory Surgical Center LLC in Media, Pennsylvania.

Dr. Chan's NPI, 1417940941, was assigned on August 30, 2005. Dr. Chan graduated from Harvard Medical School in 1994. Dr. Chan holds Pennsylvania license MD069710L.

Dr. Chan's primary practice is Leonard Dzubow Ambulatory Surgical Center LLC, at 101 Chesley Dr, Media, PA 19063 in Delaware County. The practice phone is (484) 621-0082.

Dr. Chan's primary practice is Leonard Dzubow Ambulatory Surgical Center LLC in Media, Pennsylvania. Dr. Chan is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Dermatology LTD. Dmand AI also links Dr. Chan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chan practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatopathology is Dr. Chan's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dr. Chan is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Chan's licenses on file in 3 states: Pennsylvania, California and Illinois.

Dmand AI lists acne, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, itchy rashes, minor injury on trunk, psoriasis and rash among the conditions Dr. Chan treats.

CMS data shows 10,310 Medicare services from Dr. Chan across 24 procedure codes in 2024, for 3,337 Medicare patients. Medicare paid $315,333 for them. Every service was in an office.

CMS counts 3,337 Medicare patients who saw Dr. Chan in 2024. The largest group is 65 to 74, with 1,638 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 1% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chan's median patient age at 75, with 43% women.

In 2024, Dr. Chan wrote 450 Medicare Part D claims for 249 patients. 92% of them were for generic drugs. CMS names the drug for 364 of them, across 11 drugs with 11 or more claims each, at $11,815 in total drug cost. In 2023, CMS named 330 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Chan for performance year 2024, reported as part of a group. Dr. Chan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,769 procedures of removal of skin lesions by Dr. Chan, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Chan, published from 2016 to 2022. The most frequent topics are Skin Neoplasms. Dr. Chan has published most often in Am J Dermatopathol. Dr. Chan's most frequent co-authors are Rosalie Elenitsas, MD, Emily Y. Chu, MD and Julia Dai, MD.

CMS Open Payments shows 22 general payments to Dr. Chan from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Janssen Pharmaceuticals, Inc paid the most, $167.

Dmand AI lists 2 awards for Dr. Chan, most recently Regional Top Doctor in 2014.

Dr. Chan graduated from Harvard Medical School in 1994. Dr. Chan is a member of AAD.

Dr. Chan is in network with 19 carriers, including Elevance, Excellus BlueCross BlueShield and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.